Does the RGS2 rs4606 G allele increase anxiety and sympathetic stress responses?

The RGS2 rs4606 G allele is associated with increased anxiety-related traits and heightened autonomic responses, driven by changes in G-protein signaling regulation.

Clinical and behavioral evidence

Research indicates that the RGS2 rs4606 polymorphism significantly influences susceptibility to anxiety and panic disorders. The G allele (sometimes referenced as the C allele on the opposite DNA strand) is linked to a higher risk of developing Generalized Anxiety Disorder (GAD).

• Anxiety Risk: In clinical cohorts, the presence of the risk allele has been associated with a significant increase in the odds of GAD, with some findings suggesting up to a 100% increase in risk per risk allele.
• Psychological Phenotypes: This genetic variant is further linked to panic disorder and specific anxiety-related temperaments. Animal models support these human findings; mice lacking the RGS2 gene consistently exhibit increased anxious behavior and behavioral inhibition.

Mechanistic explanations

The biological basis for these traits lies in how the rs4606 SNP affects the expression and function of the Regulator of G-protein Signaling 2 (RGS2) protein.

• Protein Expression: The rs4606 SNP is located in the 3′ untranslated region (UTR) of the RGS2 gene. The G allele is associated with reduced mRNA stability, leading to lower levels of the RGS2 protein.
• G-Protein Modulation: RGS2 normally functions as a GTPase-accelerating protein (GAP). It is responsible for "turning off" signaling from Gq/11 subunits by accelerating the hydrolysis of GTP to GDP.
• Disinhibited Signaling: When RGS2 levels are low, Gq-coupled receptors—which respond to neurotransmitters like serotonin and glutamate—remain active longer. This results in amplified and prolonged signaling, contributing to the neurobiological state of anxiety.

Autonomic and stress considerations

Beyond psychological traits, the G allele is associated with physiological hyper-responsiveness to stress due to the same regulatory deficiency.

• Sympathetic Hyperreactivity: RGS2 is a critical negative regulator of Gq-mediated signaling in the cardiovascular system. It typically dampens the effects of vasoconstrictors like angiotensin II and norepinephrine.
• Physiological Impact: Reduced RGS2 expression impairs the termination of these sympathetic signals, leading to prolonged vasoconstriction and heightened blood pressure responses.
• Recovery and Resilience: Mechanistically, this impaired termination likely results in sustained sympathetic activity and slower autonomic recovery after a stressor, although direct human heart rate recovery (HRR) data for this specific genotype is currently limited.

Bottom line

The RGS2 rs4606 G allele is a supported risk factor for increased anxiety and a plausible contributor to heightened sympathetic stress responses. It functions by reducing RGS2 protein levels, thereby removing a critical "brake" on G-protein signaling in the brain and cardiovascular system.